Pekka Sillanaukee

Chairman of Board, Ph.D, Adjunct Professor of medical biochemistry

Education & other studies:

  • Master of Natural Science, University of Jyväskylä, Natural Science Faculty, Dep. of Chemistry and Dep. of Cell Biology, 1988
  • Master of Science, University of Jyväskylä, Natural Science Faculty, Dep. of Chemistry and Dep. of Cell Biology 1989
  • Ph.D., University of Tampere, Medical Faculty, Dep. of Biomedical Science, 1992
  • Associate Professorship (docent) of Medical Biochemistry, University of Tampere, Medical Faculty, Tampere, 1993
  • Helsinki School of Economics and Business Administration, Center for Management Development, Management Executive Program, (TEJOKO 3), 1994
  • Stockholm School of Economics and Business Administration, executive Master of Business Administration (eMBA) education, 1998
  • Qualification for Assistant Professorship in Karolinska Institute, Stockholm, Sweden, 1998
  • Executive Management studies in London Business School 1998-1999

Selected positions of trust:

  • 2007 –› Chairman, Ovumia Ltd, Tampere and Nova Vita Kliinik AS, Tallinn
  • 2010 –› 2017 Chairman and member of the Board, Nordic Senior Services Ltd (Jalmari Oy, Hilmari Oy, Paavolakoti Oy, Palvelutähti Oy, Joutsenkulma Oy)
  • 2008 – 2016 Deputy Chairman and board member, Innokas Group Oy Ltd, Kempele, Helsinki, Tallinn
  • 2005 –› Chairman, OS-Service Oy, Tampere and ESO International A/S, Plc, Tallinn
  • 2000 – 2001 Expert, National Institute of Health USA (NIH), Washigton
  • 1998 – 2000 Consultant Axis-Shields Plc, Dundee, Scotland
  • 1999 – 2003 Expert memberships in several committees in Confederation of Finnish industries (EK) and Finnish Bioindustry

Pekka Sillanaukee LinkedIn profile

Loe blogi

« Tagasi